Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)

NCT02073331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1420

Last updated 2023-07-21

Study results available
· View outcomes & findings →

Summary

The objective of the study is to actively gather additional information on the use of CorMatrix ECM for pericardial reconstruction.

Conditions

  • Coronary Disease

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Green · Elutia Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02073331 on ClinicalTrials.gov